Premium Content Subscriber only The Therapeutic Goods Administration (TGA) has decided not to recognise psilocybin mushrooms (or magic mushroom) and MDMA (ecstasy) as medicines to treat a number of conditions, such as post-traumatic stress disorder, anxiety and other mental illnesses. Although the TGA's decision is not final, it goes against what advocates want. The request was raised by Mind Medicine Australia, a charity that advocates for psychedelics not to be restricted so mental health professionals can access such substances more easily. In the case of medicinal psilocybin there were 575 responses of which 553 (96 per cent) were supportive, 11 partially supportive and 11 opposed.